Cassella J P, Garrington N, Stamp T C, Ali S Y
Department of Experimental Pathology, Royal National Orthopaedic Hospital, Stanmore, Middlesex, UK.
Calcif Tissue Int. 1995 Feb;56(2):118-22. doi: 10.1007/BF00296342.
A semiquantitative electron probe X-ray microanalytical (XRMA) technique, in conjunction with transmission electron microscopy, was used to compare the calcium to phosphorus (Ca/P) molar ratios in calcium phosphate standards of known composition, in normal bone and in bone from patients with osteogenesis imperfecta (OI). Using a modified routine processing and resin embedding schedule, the measured Ca/P molar ratio of calcium phosphates standards of known composition were found to correlate well with the Ca/P molar ratio based on their respective chemical formulae. This technique was then used to compare the Ca/P molar ratio in normal human bone and in OI bone. The Ca/P ratio values for normal bone (Ca/P = 1.631) correlated well with those for chemically prepared hydroxyapatite (Ca/P = 1.602), but in bone from OI patients, the Ca/P molar ratio was significantly lower (Ca/P = 1.488). This study has shown that there is a lower Ca/P molar ratio in OI bone compared with normal, matched bone. This suggests that the mineral deviates from the carbanoapatite usually found in bone. Isomorphous substitutions in the carbanoapatite lattice could account for this although this study has neither proved nor disproved this. The altered bone mineral is another factor that could contribute to the increased fracture rate observed in OI.
一种半定量电子探针X射线微分析(XRMA)技术,结合透射电子显微镜,用于比较已知成分的磷酸钙标准品、正常骨和成骨不全(OI)患者骨中的钙磷(Ca/P)摩尔比。采用改良的常规处理和树脂包埋程序,发现已知成分的磷酸钙标准品的实测Ca/P摩尔比与其各自化学式计算的Ca/P摩尔比相关性良好。然后用该技术比较正常人骨和OI患者骨中的Ca/P摩尔比。正常骨的Ca/P比值(Ca/P = 1.631)与化学合成的羟基磷灰石的Ca/P比值(Ca/P = 1.602)相关性良好,但在OI患者的骨中,Ca/P摩尔比显著降低(Ca/P = 1.488)。本研究表明,与正常匹配骨相比,OI患者骨中的Ca/P摩尔比更低。这表明该矿物质不同于通常在骨中发现的碳羟磷灰石。虽然本研究既未证实也未否定,但碳羟磷灰石晶格中的同晶替代可能是其原因。骨矿物质的改变是导致OI患者骨折率增加的另一个因素。